U.S. CDMRP – Autism Research Program | Research Funding


Event details

Date 29.03.2023
Category Call for proposal
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Autism Research Program (ARP) Awards.

All applications for ARP funding must specifically address at least one of the Areas of Interest as directed by Congress and have direct relevance to military health; see the end of this advertisement for a list of these Areas.
Several award programs are available:
  • The Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD.
  • The Career Development Awards supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, high-impact ideas or early-phase, proof-of-principle clinical trials with the potential to have major impact on ASD.
  • The Clinical Trial Awards supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ASD.

Funding:       Idea Development Award – max. $550,000
Career Development Award – max. $550,000
Clinical Trial Award – $1.9M - $2.2M

Duration:      Idea Development Award – 3 years
Career Development Award – 3 years
Clinical Trial Award – 4  years

Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or below the level of assistant professor (or equivalent) are eligible for the Career Development Award.  All investigators at or above the level of assistant professor (or equivalent) are eligible for the Idea Development Award and Clinical Trial Award.

How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.

Grants.gov Funding Opportunity Numbers:
Pre-Application Deadline:           April 19, 2023 (5:00 p.m. Eastern time)
Full Application Deadline:            July 20, 2023

Further information
  • To find the full program announcements, use the opportunity-specific links above to connect to Grants.gov
  • For questions about the eBRAP or Grants.gov platforms, contact the Research Office.

FY23 ARP Career Development Award Areas of Interest
  • Assessment of novel therapeutics using valid preclinical models
  • Create tools and strategies to increase the speed with which evidence-based practices are deployed in community-based settings
  • Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services
  • Development of healthcare provider-focused training or tools to improve healthcare delivery for autistic individuals across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)
  • Environmental risk factors
  • Factors impacting quality of life during geographic relocation, such as military permanent change of station
  • Factors promoting success in key transitions to independence for individuals living with ASD
  • Improve diagnosis and access to services across the life span
  • Interventions to support ASD adults, including transition to adulthood, mid-life, and late life needs
  • Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions
  • Mechanisms of heterogeneous clinical expression of ASD
  • Mechanisms underlying sex differences (i.e., prevalence, biological mechanisms, phenotypic expression, core and comorbid syndrome expression and outcomes, developmental trajectories, diagnosis, and treatment response)
  • Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances,
    gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, and seizures)
  • (New for FY23) Mental health issues (such as grief, masking, suicide risk, trauma, etc.) or disorders in autistic individuals
  • Tests of implementation strategies to increase use of evidence-based practices
  • (New for FY23) Understanding heterogeneity in treatment response, including identification of psychosocial or biological factors that (1) impact treatment outcomes or (2) can be used to prospectively identify treatments that are most likely to benefit particular subgroups of individuals.
  • Understanding key factors to support ASD adults, including transition to adulthood
(New for FY23) Understanding physical health and related issues in aging autistic adults including cardiovascular issues, joint pain, asthm

Practical information

  • General public
  • Free


Event broadcasted in